In a report released yesterday, Rick Wise from Stifel Nicolaus maintained a Hold rating on Avanos Medical (AVNS – Research Report), with a price target of $22.00. The company’s shares closed yesterday at $21.52.
According to TipRanks, Wise is a 4-star analyst with an average return of 3.9% and a 55.51% success rate. Wise covers the Healthcare sector, focusing on stocks such as Atricure, Baxter International, and Boston Scientific.
The word on The Street in general, suggests a Hold analyst consensus rating for Avanos Medical with a $22.00 average price target.
See Insiders’ Hot Stocks on TipRanks >>
AVNS market cap is currently $974.5M and has a P/E ratio of -17.54.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Avanos Medical (AVNS) Company Description:
Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients’ quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Read More on AVNS:
